Analysts revise targets for Amgen, Lockheed Martin and Norfolk Southern
AMGN•Analysts raised price targets for Amgen to $480 from $450, Lockheed Martin to $600 from $550 and Norfolk Southern to $323 from $318. The roundup lists rating and price-target changes for dozens of other U.S.-listed companies.
1. Selected target changes
Oppenheimer raised its price target for Amgen to $480 from $450, RBC raised its target for Lockheed Martin to $600 from $550, and JP Morgan raised its target for Norfolk Southern to $323 from $318. The roundup also lists analyst rating and price-target changes for dozens of other U.S.-listed companies.
